Growth Metrics

Veracyte (VCYT) Tax Provisions (2021 - 2025)

Veracyte (VCYT) has disclosed Tax Provisions for 5 consecutive years, with -$552000.0 as the latest value for Q4 2025.

  • Quarterly Tax Provisions rose 67.41% to -$552000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Dec 2025, up 15.1% year-over-year, with the annual reading at $1.8 million for FY2025, 15.07% up from the prior year.
  • Tax Provisions hit -$552000.0 in Q4 2025 for Veracyte, down from -$200000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $2.2 million in Q2 2025 to a low of -$3.8 million in Q1 2021.
  • Historically, Tax Provisions has averaged -$255947.4 across 5 years, with a median of -$154000.0 in 2023.
  • Biggest five-year swings in Tax Provisions: plummeted 642.75% in 2023 and later surged 1527.0% in 2024.
  • Year by year, Tax Provisions stood at -$803000.0 in 2021, then soared by 149.81% to $400000.0 in 2022, then tumbled by 642.75% to -$2.2 million in 2023, then increased by 21.97% to -$1.7 million in 2024, then soared by 67.41% to -$552000.0 in 2025.
  • Business Quant data shows Tax Provisions for VCYT at -$552000.0 in Q4 2025, -$200000.0 in Q3 2025, and $2.2 million in Q2 2025.